Literature DB >> 22542621

Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload.

Thomas G von Lueder1, Jørgen Gravning, Ole-Jakob How, Leif E Vinge, Mohammed Shakil Ahmed, Kurt A Krobert, Finn Olav Levy, Terje S Larsen, Otto A Smiseth, Ellen Aasum, Håvard Attramadal.   

Abstract

Transgenic mice with cardiac-specific expression of a peptide inhibitor of G protein-coupled receptor kinase (GRK)3 [transgenic COOH-terminal GRK3 (GRK3ct) mice] display myocardial hypercontractility without hypertrophy and enhanced α(1)-adrenergic receptor signaling. A role for GRK3 in the pathogenesis of heart failure (HF) has not been investigated, but inhibition of its isozyme, GRK2, has been beneficial in several HF models. Here, we tested whether inhibition of GRK3 modulated evolving cardiac hypertrophy and dysfunction after pressure overload. Weight-matched male GRK3ct transgenic and nontransgenic littermate control (NLC) mice subjected to chronic pressure overload by abdominal aortic banding (AB) were compared with sham-operated (SH) mice. At 6 wk after AB, a significant increase of cardiac mass consistent with induction of hypertrophy was found, but no differences between GRK3ct-AB and NLC-AB mice were discerned. Simultaneous left ventricular (LV) pressure-volume analysis of electrically paced, ex vivo perfused working hearts revealed substantially reduced systolic and diastolic function in NLC-AB mice (n = 7), which was completely preserved in GRK3ct-AB mice (n = 7). An additional cohort was subjected to in vivo cardiac catheterization and LV pressure-volume analysis at 12 wk after AB. NLC-AB mice (n = 11) displayed elevated end-diastolic pressure (8.5 ± 3.1 vs. 2.9 ± 1.2 mmHg, P < 0.05), reduced cardiac output (3,448 ± 323 vs. 4,488 ± 342 μl/min, P < 0.05), and reduced dP/dt(max) and dP/dt(min) (both P < 0.05) compared with GRK3ct-AB mice (n = 16), corroborating the preserved cardiac structure and function observed in GRK3ct-AB hearts assessed ex vivo. Increased cardiac mass and myocardial mRNA expression of β-myosin heavy chain confirmed the similar induction of cardiac hypertrophy in both AB groups, but only NLC-AB hearts displayed significantly elevated mRNA levels of brain natriuretic peptide and myocardial collagen contents as well as reduced β(1)-adrenergic receptor responsiveness to isoproterenol, indicating increased LV wall stress and the transition to HF. Inhibition of cardiac GRK3 in mice does not alter the hypertrophic response but attenuates cardiac dysfunction and HF after chronic pressure overload.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542621     DOI: 10.1152/ajpheart.00724.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  10 in total

Review 1.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms.

Authors:  Gaetano Santulli; Bruno Trimarco; Guido Iaccarino
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-03-27

Review 3.  Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.

Authors:  Brian C Jensen; Timothy D OʼConnell; Paul C Simpson
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

Review 4.  Noncanonical Roles of G Protein-coupled Receptor Kinases in Cardiovascular Signaling.

Authors:  Sarah M Schumacher; Walter J Koch
Journal:  J Cardiovasc Pharmacol       Date:  2017-09       Impact factor: 3.105

Review 5.  Nuclear compartmentalization of α1-adrenergic receptor signaling in adult cardiac myocytes.

Authors:  Steven C Wu; Timothy D OʼConnell
Journal:  J Cardiovasc Pharmacol       Date:  2015-02       Impact factor: 3.105

6.  Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling.

Authors:  Chen-Ze Zhao; Xu-Ming Zhao; Jian Yang; Yun Mou; Bin Chen; Huan-Dong Wu; Dong-Pu Dai; Jie Ding; Shen-Jiang Hu
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

Review 7.  G Protein-Coupled Receptor Kinases: Crucial Regulators of Blood Pressure.

Authors:  Jian Yang; Van Anthony M Villar; Ines Armando; Pedro A Jose; Chunyu Zeng
Journal:  J Am Heart Assoc       Date:  2016-07-07       Impact factor: 5.501

Review 8.  Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular Disease.

Authors:  Laurel A Grisanti; Sarah M Schumacher; Douglas G Tilley; Walter J Koch
Journal:  JACC Basic Transl Sci       Date:  2018-08-28

Review 9.  Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling.

Authors:  Supachoke Mangmool; Warisara Parichatikanond; Hitoshi Kurose
Journal:  Front Pharmacol       Date:  2018-11-27       Impact factor: 5.810

10.  Inactivation of Myosin binding protein C homolog in zebrafish as a model for human cardiac hypertrophy and diastolic dysfunction.

Authors:  Yau-Hung Chen; Chiung-Wen Pai; Shu-Wei Huang; Sheng-Nan Chang; Lian-Yu Lin; Fu-Tien Chiang; Jiunn-Lee Lin; Juey-Jen Hwang; Chia-Ti Tsai
Journal:  J Am Heart Assoc       Date:  2013-09-18       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.